Department of Interventional Pulmonology, Institute for Pulmonary Diseases of Vojvodina, Clinic for Pulmonary Oncology, Sremska Kamenica, Serbia.
Ann Thorac Med. 2013 Apr;8(2):93-8. doi: 10.4103/1817-1737.109820.
The search for the most efficient bronchoscopic imaging tool in detection of early lung cancer is still active. The major aim of this study was to determine sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of each bronchoscopic technique and their combination in detection of premalignant bronchial lesions.
This was a prospective trial that enrolled 96 patients with indication for bronchoscopy. Lesions were classified as visually positive if pathological fluorescence was observed under autofluorescence imaging (AFI) videobronchoscopy or dotted, tortuous, and abrupt-ending blood vessels were identified under narrow band imaging (NBI) videobronchoscopy. Squamous metaplasia, mild, moderate, or severe dysplasia, and carcinoma in situ (CIS) were regarded as histologically positive lesions.
Sensitivity, specificity, PPV, and NPV of white light videobronchoscopy (WLB) in detection of premalignant lesions were 26.5%, 63.9%, 34.4%, and 54.9%, respectively; the corresponding values for AFI were 52%, 79.6%, 64.6%, and 69.9% respectively, for NBI were 66%, 84.6%, 75.4%, 77.7%, respectively, while the values for combination of NBI and AFI were 86.1%, 86.6%, 84.6%, and 88%, respectively. Combination of NBI and AFI significantly improves sensitivity when compared to each individual technique (P < 0.001). When specificity is of concern, combination of techniques improves specificity of WLB (P < 0.001) and specificity of AFI (P = 0.03), but it does not have significant influence on specificity of NBI (P = 0.53).
Combination of NBI and AFI in detection of premalignant bronchial lesions increases both sensitivity and specificity of each technique. However, it seems that NBI is most sufficient and effective in detection of these lesions.
寻找最有效的支气管镜检查成像工具以检测早期肺癌的研究仍在进行中。本研究的主要目的是确定每种支气管镜技术及其组合在检测癌前支气管病变中的敏感性、特异性、阳性预测值(PPV)和阴性预测值(NPV)。
这是一项前瞻性试验,纳入了 96 例有支气管镜检查适应证的患者。如果在荧光支气管镜(AFI)下观察到病理性荧光,则将病变分类为视觉阳性,如果在窄带成像(NBI)支气管镜下识别出点状、扭曲和突然终止的血管,则将病变分类为视觉阳性。鳞状上皮化生、轻度、中度或重度异型增生和原位癌(CIS)被视为组织学阳性病变。
白光支气管镜(WLB)检测癌前病变的敏感性、特异性、PPV 和 NPV 分别为 26.5%、63.9%、34.4%和 54.9%;AFI 的相应值分别为 52%、79.6%、64.6%和 69.9%;NBI 的相应值分别为 66%、84.6%、75.4%和 77.7%;而 NBI 和 AFI 联合的相应值分别为 86.1%、86.6%、84.6%和 88%。与单独使用任何一种技术相比,联合使用 NBI 和 AFI 可显著提高敏感性(P <0.001)。当关注特异性时,联合使用技术可提高 WLB(P <0.001)和 AFI(P=0.03)的特异性,但对 NBI 的特异性无显著影响(P=0.53)。
NBI 和 AFI 联合检测癌前支气管病变可提高每种技术的敏感性和特异性。然而,NBI 似乎在检测这些病变方面最充分和有效。